CIA
ARNA

CSat Investment Advisory’s Arena Pharmaceuticals Inc ARNA Stock Holding History

CSat Investment Advisory’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,224
Closed -$468K – 1088
2019
Q3 		$468K Buy
+10,224
New +$575K 0.15% 135

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CSat Investment Advisory's ARNA Position: Q4 2019 in Review

CSat Investment Advisory sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2019, closing a stake of 10,224 shares — an estimated $468K sold.

CSat Investment Advisory first reported a position in ARNA in Q3 2019 and held it in 1 quarter. The position peaked at $468K in Q3 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

  • CSat Investment Advisory reported no remaining Arena Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
  • CSat Investment Advisory sold 10,224 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $468K.
  • CSat Investment Advisory first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 1 quarter.
  • CSat Investment Advisory's Arena Pharmaceuticals Inc position peaked at $468K in Q3 2019.
  • 226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on CSat Investment Advisory's 13F filing for Q4 2019, filed 13 Feb 2020.